{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T19:55:31Z","timestamp":1717790131552},"reference-count":19,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Physiologica Hungarica"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1556\/aphysiol.99.2012.2.15","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T05:32:42Z","timestamp":1343799162000},"page":"216-222","source":"Crossref","is-referenced-by-count":4,"title":["Factors influencing skin autofluorescence of patients with peritoneal dialysis"],"prefix":"10.1556","volume":"99","author":[{"given":"Em\u00edlia","family":"M\u00e1csai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Cseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"V\u00e1s\u00e1rhelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1525-139X.2011.00946.x","article-title":"Should nonglucose containing peritoneal dialysis solutions be used in all patients to avoid long-term membrane injury?","volume":"24","author":"Blake P.G.","year":"2011","journal-title":"Semin. Dial."},{"key":"2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ndt\/gfq378","article-title":"Proteome profile of peritoneal effluents in children on glucose- or icodextrin-based peritoneal dialysis","volume":"26","author":"Bruschi M.","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2009.06.005","article-title":"Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies","volume":"36","author":"Daroux M.","year":"2010","journal-title":"Diabetes Metab."},{"key":"4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/089686080902900402","article-title":"Icodextrin metabolites in peritoneal dialysis","volume":"29","author":"Garc\u00eda-L\u00f3pez E.","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits E.G.","year":"2008","journal-title":"Diabetes Care"},{"key":"6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfn634","article-title":"AGEs, autofluorescence and renal function","volume":"24","author":"Gerrits E.G.","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1177\/193229680900300629","article-title":"Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution","volume":"3","author":"Holmes C.J.","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"8","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1177\/089686080702702s29","article-title":"Can we overcome the predestined poor survival of diabetic patients? Perspectives from pre- and postdialysis","volume":"27","author":"Kim Y.L.","year":"2007","journal-title":"Perit. Dial. Int."},{"key":"9","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1177\/089686080702702s33","article-title":"Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?","volume":"27","author":"Kuriyama S.","year":"2007","journal-title":"Perit. Dial. Int."},{"key":"10","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/dc05-2173","article-title":"Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes","volume":"29","author":"Lutgers H.L.","year":"2006","journal-title":"Diabetes Care"},{"key":"11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers H.L.","year":"2009","journal-title":"Diabetologia"},{"key":"12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2215\/CJN.05350709","article-title":"Tissueadvanced glycation end product concentration in dialysis patients","volume":"5","author":"McIntyre N.J.","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"13","doi-asserted-by":"crossref","unstructured":"McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW: Skin Autofluorescence and the Association with Renal and Cardiovascular Risk Factors in Chronic Kidney Disease Stage 3. Clin. J. Am. Soc. Nephrol. Sept. 1. (2011)","DOI":"10.2215\/CJN.02420311"},{"key":"14","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt R.","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2008.08.031","article-title":"Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis","volume":"53","author":"Meerwaldt R.","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"16","first-page":"336","article-title":"Patients on peritoneal dialysis with type 2 diabetes have poorer outcomes than non-diabetics due to preceding cardiovascular comorbidity","volume":"29","author":"Portol\u00e9s J.","year":"2009","journal-title":"Nefrolog\u00eda"},{"key":"17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ndt\/gfm148","article-title":"Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content","volume":"22","author":"Schmitt C.P.","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"18","first-page":"CR75","article-title":"Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis","volume":"16","author":"Skubala A.","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1523-1755.2003.00705.x","article-title":"Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?","volume":"63","author":"Zeier M.","year":"2003","journal-title":"Kidney Int."}],"container-title":["Acta Physiologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/aphysiol.99.2012.2.15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T01:48:04Z","timestamp":1643075284000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/aphysiol.99.2012.2.15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1556\/APhysiol.99.2012.2.15"],"URL":"https:\/\/doi.org\/10.1556\/aphysiol.99.2012.2.15","relation":{},"ISSN":["0231-424X","1588-2683"],"issn-type":[{"value":"0231-424X","type":"print"},{"value":"1588-2683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}